133 related articles for article (PubMed ID: 15156159)
1. Promoter hypermethylation silences cyclooxygenase-2 (Cox-2) and regulates growth of human hepatocellular carcinoma cells.
Murata H; Tsuji S; Tsujii M; Sakaguchi Y; Fu HY; Kawano S; Hori M
Lab Invest; 2004 Aug; 84(8):1050-9. PubMed ID: 15156159
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H
Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
4. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
Leng J; Han C; Demetris AJ; Michalopoulos GK; Wu T
Hepatology; 2003 Sep; 38(3):756-68. PubMed ID: 12939602
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma.
Yang XX; Sun JZ; Li FX; Wu YS; Du HY; Zhu W; Li XH; Li M
World J Gastroenterol; 2012 Jun; 18(21):2719-26. PubMed ID: 22690083
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
[TBL] [Abstract][Full Text] [Related]
9. Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.
Sun JZ; Yang XX; Li XH; Xu WW; Wang Y; Zhu W; Li M
Dig Dis Sci; 2011 Oct; 56(10):3072-7. PubMed ID: 21448695
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.
Zhang X; Yang Y; Liu X; Herman JG; Brock MV; Licchesi JD; Yue W; Pei X; Guo M
Epigenetics; 2013 Apr; 8(4):373-82. PubMed ID: 23449122
[TBL] [Abstract][Full Text] [Related]
11. Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP).
Tran DDH; Koch A; Allister A; Saran S; Ewald F; Koch M; Nashan B; Tamura T
Cell Signal; 2016 Dec; 28(12):1872-1880. PubMed ID: 27619201
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma.
Li H; Zhang M; Linghu E; Zhou F; Herman JG; Hu L; Guo M
Clin Epigenetics; 2018 Nov; 10(1):137. PubMed ID: 30400968
[TBL] [Abstract][Full Text] [Related]
13. NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines.
Cheng J; Imanishi H; Amuro Y; Hada T
Int J Cancer; 2002 Jun; 99(5):755-61. PubMed ID: 12115513
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
[TBL] [Abstract][Full Text] [Related]
15. PPARdelta activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells.
Glinghammar B; Skogsberg J; Hamsten A; Ehrenborg E
Biochem Biophys Res Commun; 2003 Aug; 308(2):361-8. PubMed ID: 12901877
[TBL] [Abstract][Full Text] [Related]
16. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma.
Yan Q; Zhang ZF; Chen XP; Gutmann DH; Xiong M; Xiao ZY; Huang ZY
Int J Oncol; 2008 May; 32(5):1057-63. PubMed ID: 18425332
[TBL] [Abstract][Full Text] [Related]
17. The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line.
Fantappiè O; Masini E; Sardi I; Raimondi L; Bani D; Solazzo M; Vannacci A; Mazzanti R
Hepatology; 2002 Apr; 35(4):843-52. PubMed ID: 11915030
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.
Yuan BZ; Durkin ME; Popescu NC
Cancer Genet Cytogenet; 2003 Jan; 140(2):113-7. PubMed ID: 12645648
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation regulates cyclooxygenase expression in breast cancer.
Ma X; Yang Q; Wilson KT; Kundu N; Meltzer SJ; Fulton AM
Breast Cancer Res; 2004; 6(4):R316-21. PubMed ID: 15217498
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas.
Jin J; You H; Yu B; Deng Y; Tang N; Yao G; Shu H; Yang S; Qin W
Biochem Biophys Res Commun; 2009 Jan; 379(1):86-91. PubMed ID: 19100240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]